| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 56 | 27.9x | 17.8x | Around median | |
Growth | 58 | 24.3% | 7.1% | Around median | |
Quality | 42 | 11.9% | 4.5% | Around median | |
Safety | 55 | 2.7x | 2.6x | Around median | |
Capital Return | 29 | 0.00% | 2.12% | Bottom tier | |
Momentum | 99 | 52.0% | 2.9% | Top tier | |
Sentiment | 23 | 3 | 3 | Bottom tier |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
CoreCivic operates correctional, detention, and reentry facilities, provides complementary services to the corrections sector, and leases specialized properties to government agencies. Following the segment redefinition in Q2 fiscal 2026, the CoreCivic Residential segment now includes 64 company-managed facilities, while CoreCivic Services includes Clinical Solutions Pharmacy services, transportation through TransCore, and electronic monitoring and case management through Recovery Monitoring Solutions, and CoreCivic Properties includes five facilities leased to government entities. Federal partners, particularly ICE and US Marshals Service, represented approximately 53% of total revenue during the quarter, making detainee volumes and government contracts the primary drivers of the business.
Revenue for Q2 fiscal 2026 was approximately $684.9 million, compared with $614.7 million in Q1 fiscal 2026, while net income was $37.1 million and GAAP earnings per share were $0.37. The company reported adjusted earnings per share of $0.38 and normalized FFO of $0.64 per share, while adjusted EBITDA reached $109.4 million; excluding employee retention credits from the comparison period, adjusted earnings per share increased 35.7% and adjusted EBITDA rose 19.3% year over year.
Occupancy in the CoreCivic Residential segment was approximately 78.4% in Q2 fiscal 2026, up 1.6 percentage points year over year, and the average daily population across all managed facilities reached 66.4 thousand versus 54 thousand a year earlier. The Residential segment generated 92.4% of segment net operating income at an operating margin of 22.4%, while the Services segment achieved a margin of 10.2% and contributed 6.1% of segment net operating income following the addition of Clinical Solutions Pharmacy.
Automated analysis for informational purposes only — not investment advice.
The average analyst price target is $37.5, within a range of $35 to $40, with a consensus Buy rating; the average is approximately 7.6% above the 52-week range high of $34.86, while the annual range extends to a low of $15.74. No valid price-to-earnings ratio is available in the data, but management estimated the enterprise value-to-EBITDA multiple at approximately 6 times, compared with a 20-year historical average of 9.5 times, and the wide 52-week range reflects a revaluation associated with the large facility sales, debt reduction, and growth in ICE demand, offset by uncertainty regarding the contract terms for the sold facilities and future margins.
Figures in the text are as of 2026-08-31; the live price is shown at the top of the page.
Revenue was $684.9 million, net income was $37.1 million, and GAAP earnings per share were $0.37. Adjusted earnings per share were $0.38 and normalized FFO was $0.64 per share, while adjusted EBITDA was $109.4 million. Excluding employee retention credits from the comparison period, adjusted EBITDA grew 19.3% and adjusted earnings per share increased 35.7% year over year.
CoreCivic sold California City Detention Facility and Otay Mesa Detention Center on July 2, 2026, for a combined $1.5 billion, then sold Midwest Regional Reception Center and Prairie Correctional Facility for $734 million. The company estimated net proceeds from the four transactions at approximately $1.6 billion after taxes and costs, while continuing to manage the facilities under existing contracts. It used part of the proceeds to repay $608.5 million of debt, but warned that the management contract terms could be amended as a result of the ownership transfer.
Federal partners accounted for 53% of CoreCivic's total revenue in Q2 fiscal 2026. ICE revenue increased by $91.3 million, or 51.6%, while US Marshals Service revenue declined by $14.1 million compared with the prior period. The number of ICE individuals in the company's care also increased by approximately 6 thousand people, or 59.6%, from the beginning of fiscal 2025 through June 30, 2026.
Management expects adjusted diluted earnings per share of between $1.62 and $1.70 and normalized FFO of between $2.61 and $2.70 per share in fiscal 2026. The adjusted EBITDA range is $440.5–$445.5 million, while AFFO is expected to be between $257.5 million and $271.5 million. The guidance includes the estimated impact of the facility sales and a modest increase in resident populations, but excludes any share repurchases in the second half of fiscal 2026 or any potential additional facility sales.
On August 4, 2026, the board increased the existing authorization by $500 million, bringing available capacity to $755.8 million. Since May 2022, the company has repurchased 28.1 million shares at a total cost of $444.2 million and an average of $15.82 per share. The 8.9% reduction in the weighted average diluted share count helped support per-share results for Q2 fiscal 2026, but using cash for new repurchases would reduce interest income and could negatively affect aggregate metrics before accounting for the impact of the lower share count.
The company continues to increase occupancy at the 2.56 thousand-bed California City Detention Facility and the 2.16 thousand-bed Diamondback Correctional Facility, which housed 1,674 and 1,522 individuals, respectively, on June 30, 2026. It also began activating the 1.6 thousand-bed Prairie Correctional Facility, with detainee intake expected to begin in Q4 fiscal 2026 and full activation expected in Q2 fiscal 2027. In addition, CoreCivic retains four idle facilities containing approximately 5.5 thousand beds, but management did not provide timing for new contracts covering them.
